Your browser doesn't support javascript.
loading
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML.
Trinh, Bon Q; Ummarino, Simone; Zhang, Yanzhou; Ebralidze, Alexander K; Bassal, Mahmoud A; Nguyen, Tuan M; Heller, Gerwin; Coffey, Rory; Tenen, Danielle E; van der Kouwe, Emiel; Fabiani, Emiliano; Gurnari, Carmelo; Wu, Chan-Shuo; Angarica, Vladimir Espinosa; Yang, Henry; Chen, Sisi; Zhang, Hong; Thurm, Abby R; Marchi, Francisco; Levantini, Elena; Staber, Philipp B; Zhang, Pu; Voso, Maria Teresa; Pandolfi, Pier Paolo; Kobayashi, Susumu S; Chai, Li; Di Ruscio, Annalisa; Tenen, Daniel G.
Afiliação
  • Trinh BQ; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Ummarino S; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Zhang Y; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Ebralidze AK; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Bassal MA; Harvard Stem Cell Institute, Harvard University, Boston, MA.
  • Nguyen TM; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Heller G; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Coffey R; Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Tenen DE; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • van der Kouwe E; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Fabiani E; Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Gurnari C; Division of Hematology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Wu CS; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Angarica VE; Saint Camillus International University of Health Sciences, Rome, Italy.
  • Yang H; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Chen S; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Zhang H; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Thurm AR; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Marchi F; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Levantini E; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Staber PB; Harvard Stem Cell Institute, Harvard University, Boston, MA.
  • Zhang P; Stanford University School of Medicine, Stanford, CA.
  • Voso MT; Harvard Stem Cell Institute, Harvard University, Boston, MA.
  • Pandolfi PP; University of Florida, Gainesville, FL.
  • Kobayashi SS; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA.
  • Chai L; Harvard Stem Cell Institute, Harvard University, Boston, MA.
  • Di Ruscio A; Institute of Biomedical Technologies, National Research Council (CNR), Area della Ricerca di Pisa, Pisa, Italy.
  • Tenen DG; Division of Hematology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Blood ; 138(15): 1331-1344, 2021 10 14.
Article em En | MEDLINE | ID: mdl-33971010
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteínas de Fusão Oncogênica / Subunidade alfa 2 de Fator de Ligação ao Core / RNA Longo não Codificante / Proteína 1 Parceira de Translocação de RUNX1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteínas de Fusão Oncogênica / Subunidade alfa 2 de Fator de Ligação ao Core / RNA Longo não Codificante / Proteína 1 Parceira de Translocação de RUNX1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article